Serial #79375534
LIVE

Serial Number

79375534

Owner

Angelini Holding S.P.A.

Attorney

John Zaccaria

Filing Date

May 18, 2023

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79375534 Trademark

Serial Number: 79375534 • Registration: 7602120

Serial #79375534 is a trademark filed by Angelini Holding S.P.A. on May 18, 2023. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Angelini Holding S.P.A.

Viale Amelia 70

Entity Type: 99

Trademark Details

Filing Date

May 18, 2023

Registration Date

December 17, 2024

Published for Opposition

October 15, 2024

Goods & Services

Pharmaceutical preparations for the central nervous system; pharmaceutical preparations for the treatment of central nervous system (CNS) diseases; pharmaceutical preparations for treating peripheral nervous system disorders; stimulants for the central nervous system; pharmaceutical agents affecting peripheral nervous system; pharmaceutical preparations for the treatment of epilepsy, pharmaceuticals for the treatment of epilepsy and brain health, fever and colds, autoimmune diseases, bacteria-based diseases, bone diseases, cardiovascular and cerebrovascular diseases, central nervous system diseases, diabetes, diseases and disorders of the endocrine system, diseases and disorders of the genitourinary system, diseases and disorders of the musculoskeletal system, eye diseases and conditions, gastrointestinal diseases, gynecological diseases, infectious diseases, inflammatory diseases, insomnia, kidney diseases, metabolic diseases and disorders, neuropathic pain, ocular disorders, pain, respiratory diseases, seizures, sinus congestion, skeletal diseases, skin diseases, and viral diseases, chemico-pharmaceutical preparations for disinfecting and sanitizing, for intimate gynaecological and body hygiene; chemical preparations for pharmaceutical purposes for the treatment of epilepsy and brain health, fever and colds, autoimmune diseases, bacteria-based diseases, bone diseases, cardiovascular and cerebrovascular diseases, central nervous system diseases, diabetes, diseases and disorders of the endocrine system, diseases and disorders of the genitourinary system, diseases and disorders of the musculoskeletal system, eye diseases and conditions, gastrointestinal diseases, gynecological diseases, infectious diseases, inflammatory diseases, insomnia, kidney diseases, metabolic diseases and disorders, neuropathic pain, ocular disorders, pain, respiratory diseases, seizures, sinus congestion, skeletal diseases, skin diseases, and viral diseases; milk ferments for pharmaceutical purposes; decoctions for pharmaceutical purposes for the treatment of epilepsy and brain health, fever and colds, autoimmune diseases, bacteria-based diseases, bone diseases, cardiovascular and cerebrovascular diseases, central nervous system diseases, diabetes, diseases and disorders of the endocrine system, diseases and disorders of the genitourinary system, diseases and disorders of the musculoskeletal system, eye diseases and conditions, gastrointestinal diseases, gynecological diseases, infectious diseases, inflammatory diseases, insomnia, kidney diseases, metabolic diseases and disorders, neuropathic pain, ocular disorders, pain, respiratory diseases, seizures, sinus congestion, skeletal diseases, skin diseases, and viral diseases; digestives for pharmaceutical purposes; ferments for pharmaceutical purposes; lotions for pharmaceutical purposes for the treatment of epilepsy and brain health, fever and colds, autoimmune diseases, bacteria-based diseases, bone diseases, cardiovascular and cerebrovascular diseases, central nervous system diseases, diabetes, diseases and disorders of the endocrine system, diseases and disorders of the genitourinary system, diseases and disorders of the musculoskeletal system, eye diseases and conditions, gastrointestinal diseases, gynecological diseases, infectious diseases, inflammatory diseases, insomnia, kidney diseases, metabolic diseases and disorders, neuropathic pain, ocular disorders, pain, respiratory diseases, seizures, sinus congestion, skeletal diseases, skin diseases, and viral diseases; pastilles for pharmaceutical purposes for the treatment of epilepsy and brain health, fever and colds, autoimmune diseases, bacteria-based diseases, bone diseases, cardiovascular and cerebrovascular diseases, central nervous system diseases, diabetes, diseases and disorders of the endocrine system, diseases and disorders of the genitourinary system, diseases and disorders of the musculoskeletal system, eye diseases and conditions, gastrointestinal diseases, gynecological diseases, infectious diseases, inflammatory diseases, insomnia, kidney diseases, metabolic diseases and disorders, neuropathic pain, ocular disorders, pain, respiratory diseases, seizures, sinus congestion, skeletal diseases, skin diseases, and viral diseases; propolis for pharmaceutical purposes for the treatment of throat and oral cavity conditions; syrups for pharmaceutical purposes for the treatment of epilepsy and brain health, fever and colds, autoimmune diseases, bacteria-based diseases, bone diseases, cardiovascular and cerebrovascular diseases, central nervous system diseases, diabetes, diseases and disorders of the endocrine system, diseases and disorders of the genitourinary system, diseases and disorders of the musculoskeletal system, eye diseases and conditions, gastrointestinal diseases, gynecological diseases, infectious diseases, inflammatory diseases, insomnia, kidney diseases, metabolic diseases and disorders, neuropathic pain, ocular disorders, pain, respiratory diseases, seizures, sinus congestion, skeletal diseases, skin diseases, and viral diseases; ointments for pharmaceutical purposes for the treatment of epilepsy and brain health, fever and colds, autoimmune diseases, bacteria-based diseases, bone diseases, cardiovascular and cerebrovascular diseases, central nervous system diseases, diabetes, diseases and disorders of the endocrine system, diseases and disorders of the genitourinary system, diseases and disorders of the musculoskeletal system, eye diseases and conditions, gastrointestinal diseases, gynecological diseases, infectious diseases, inflammatory diseases, insomnia, kidney diseases, metabolic diseases and disorders, neuropathic pain, ocular disorders, pain, respiratory diseases, seizures, sinus congestion, skeletal diseases, skin diseases, and viral diseases; pharmaceutical preparations for skin care; vitamin supplement patches; dietary supplements with a cosmetic effect; royal jelly dietary supplements; pollen dietary supplements; propolis dietary supplements; nutritional supplements; dietetic foods adapted for medical purposes; analgesics; anaesthetics; antibiotics; anti-inflammatories; antioxidant pills being food supplements; antiseptics; balms for medical purposes; medicated sweets; collyrium; cachets for pharmaceutical purposes for the treatment of epilepsy and brain health, fever and colds, autoimmune diseases, bacteria-based diseases, bone diseases, cardiovascular and cerebrovascular diseases, central nervous system diseases, diabetes, diseases and disorders of the endocrine system, diseases and disorders of the genitourinary system, diseases and disorders of the musculoskeletal system, eye diseases and conditions, gastrointestinal diseases, gynecological diseases, infectious diseases, inflammatory diseases, insomnia, kidney diseases, metabolic diseases and disorders, neuropathic pain, ocular disorders, pain, respiratory diseases, seizures, sinus congestion, skeletal diseases, skin diseases, and viral diseases; adhesive plasters for medical purposes; medicated toothpaste, mineral dietary supplements; medicines for human purposes for the treatment of epilepsy and brain health, fever and colds, autoimmune diseases, bacteria-based diseases, bone diseases, cardiovascular and cerebrovascular diseases, central nervous system diseases, diabetes, diseases and disorders of the endocrine system, diseases and disorders of the genitourinary system, diseases and disorders of the musculoskeletal system, eye diseases and conditions, gastrointestinal diseases, gynecological diseases, infectious diseases, inflammatory diseases, insomnia, kidney diseases, metabolic diseases and disorders, neuropathic pain, ocular disorders, pain, respiratory diseases, seizures, sinus congestion, skeletal diseases, skin diseases, and viral diseases; medicines for dental purposes; medicines for veterinary purposes for the treatment of epilepsy and brain health, autoimmune diseases, bacteria-based diseases, bone diseases, cardiovascular and cerebrovascular diseases, central nervous system diseases, diabetes, diseases and disorders of the endocrine system, diseases and disorders of the genitourinary system, diseases and disorders of the musculoskeletal system, eye diseases and conditions, gastrointestinal diseases, infectious diseases, inflammatory diseases, kidney diseases, metabolic diseases and disorders, neuropathic pain, ocular disorders, pain, respiratory diseases, seizures, skeletal diseases, skin diseases, and viral diseases; chemical preparations for medical purposes for the treatment of epilepsy and brain health, fever and colds, autoimmune diseases, bacteria-based diseases, bone diseases, cardiovascular and cerebrovascular diseases, central nervous system diseases, diabetes, diseases and disorders of the endocrine system, diseases and disorders of the genitourinary system, diseases and disorders of the musculoskeletal system, eye diseases and conditions, gastrointestinal diseases, gynecological diseases, infectious diseases, inflammatory diseases, insomnia, kidney diseases, metabolic diseases and disorders, neuropathic pain, ocular disorders, pain, respiratory diseases, seizures, sinus congestion, skeletal diseases, skin diseases, and viral diseases; chemical preparations for veterinary purposes for the treatment of epilepsy and brain health, autoimmune diseases, bacteria-based diseases, bone diseases, cardiovascular and cerebrovascular diseases, central nervous system diseases, diabetes, diseases and disorders of the endocrine system, diseases and disorders of the genitourinary system, diseases and disorders of the musculoskeletal system, eye diseases and conditions, gastrointestinal diseases, infectious diseases, inflammatory diseases, kidney diseases, metabolic diseases and disorders, neuropathic pain, ocular disorders, pain, respiratory diseases, seizures, skeletal diseases, skin diseases, and viral diseases; nutraceutical preparations for therapeutic or medical purposes for the treatment of epilepsy and brain health, autoimmune diseases, bacteria-based diseases, bone diseases, cardiovascular and cerebrovascular diseases, central nervous system diseases, diabetes, diseases and disorders of the endocrine system, diseases and disorders of the genitourinary system, diseases and disorders of the musculoskeletal system, eye diseases and conditions, gastrointestinal diseases, infectious diseases, inflammatory diseases, kidney diseases, metabolic diseases and disorders, neuropathic pain, ocular disorders, pain, respiratory diseases, seizures, skeletal diseases, skin diseases, and viral diseases; pharmaceutical preparations for the treatment of epilepsy and brain health, autoimmune diseases, bacteria-based diseases, bone diseases, cardiovascular and cerebrovascular diseases, central nervous system diseases, diabetes, diseases and disorders of the endocrine system, diseases and disorders of the genitourinary system, diseases and disorders of the musculoskeletal system, eye diseases and conditions, gastrointestinal diseases, infectious diseases, inflammatory diseases, kidney diseases, metabolic diseases and disorders, neuropathic pain, ocular disorders, pain, respiratory diseases, seizures, skeletal diseases, skin diseases, and viral diseases; mouthwashes for medical purposes; veterinary preparations, namely, veterinary vaccines; purgatives; dietetic substances in the nature of foods, capsules, confectionery, beverages, infusions, syrups, tablets adapted for medical use; suppositories being pharmaceutical preparations for the prevention and/or treatment of epilepsy and brain health, autoimmune diseases, bacteria-based diseases, bone diseases, cardiovascular and cerebrovascular diseases, central nervous system diseases, diabetes, diseases and disorders of the endocrine system, diseases and disorders of the genitourinary system, diseases and disorders of the musculoskeletal system, eye diseases and conditions, gastrointestinal diseases, infectious diseases, inflammatory diseases, kidney diseases, metabolic diseases and disorders, neuropathic pain, ocular disorders, pain, respiratory diseases, seizures, skeletal diseases, skin diseases, and viral diseases; herbal teas for medicinal purposes

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Jun 13, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
May 24, 2025 FICS
FINAL DISPOSITION PROCESSED
May 24, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 17, 2025 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jan 17, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 1, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jan 1, 2025 OPNR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 17, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 17, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 15, 2024 NPUB
PUBLISHED FOR OPPOSITION
Oct 15, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 25, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 10, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 6, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 6, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 6, 2024 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 6, 2024 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Sep 6, 2024 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 6, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 6, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 6, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sep 6, 2024 COAR
REFUSAL PROCESSED BY IB
Apr 2, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 13, 2024 RFCS
REFUSAL PROCESSED BY MPU
Mar 13, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 21, 2024 RFCR
NON-FINAL ACTION WRITTEN
Feb 20, 2024 CNRT
ASSIGNED TO EXAMINER
Feb 12, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Aug 8, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 4, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 3, 2023 REPR